A Phase 3, Multicenter Study Designed To Evaluate The Efficacy And Safety Of A Long Acting Hgh Product (Mod-4023) In Adult Subjects With Growth Hormone Deficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01909479
Recruitment Status : Terminated (Main Study was completed. LT-OLE was discontinued as sufficient safety data has been generated.)
First Posted : July 26, 2013
Last Update Posted : August 23, 2018
Information provided by (Responsible Party):
Opko Biologics

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2016
  Actual Study Completion Date : August 2018